Acadia Pharma (ACAD) Misses Q1 EPS by 10c; Offers FY22 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 20.76 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.76 | 52 Week High | $42.49 | |||
| Open | $20.76 | 52 Week Low | $16.64 | |||
| Day High | $20.76 | P/E | N/A | |||
| Day Low | $20.76 | EPS | $-0.42 | |||
| Volume | 5 | |||||
